“This transaction clearly confirms that the company has been highly successful in becoming a preeminent global leader in the medical cannabis industry,” Zettl said. The new offer and the transaction are subject to customary closing conditions, including Competition Act approval. The deal also means … Read More
The post Aurora Cannabis to buy CanniMed Therapeutics in friendly deal valued at $1.1B appeared first on Dagga Magazine.